The immunostimulatory cytokine Interleukin-2 (IL-2) has shown potency for autoimmune disease treatment [5,6,7,8] as well as adverse effects [9,10,11], which deserve more investment to develop its therapeutic potential. This evidence concerns the gene IL2 and autoimmune disease.